These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 23830046)

  • 21. A novel atypical hemolytic uremic syndrome-associated hybrid CFHR1/CFH gene encoding a fusion protein that antagonizes factor H-dependent complement regulation.
    Valoti E; Alberti M; Tortajada A; Garcia-Fernandez J; Gastoldi S; Besso L; Bresin E; Remuzzi G; Rodriguez de Cordoba S; Noris M
    J Am Soc Nephrol; 2015 Jan; 26(1):209-19. PubMed ID: 24904082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factor H-related proteins.
    Józsi M; Meri S
    Methods Mol Biol; 2014; 1100():225-36. PubMed ID: 24218263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atypical hemolytic uremic syndrome associated with complement factor H autoantibodies and CFHR1/CFHR3 deficiency.
    Lee BH; Kwak SH; Shin JI; Lee SH; Choi HJ; Kang HG; Ha IS; Lee JS; Dragon-Durey MA; Choi Y; Cheong HI
    Pediatr Res; 2009 Sep; 66(3):336-40. PubMed ID: 19531976
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Piras R; Valoti E; Alberti M; Bresin E; Mele C; Breno M; Liguori L; Donadelli R; Rigoldi M; Benigni A; Remuzzi G; Noris M
    Front Immunol; 2022; 13():1011580. PubMed ID: 36793547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding of the human complement regulators CFHR1 and factor H by streptococcal collagen-like protein 1 (Scl1) via their conserved C termini allows control of the complement cascade at multiple levels.
    Reuter M; Caswell CC; Lukomski S; Zipfel PF
    J Biol Chem; 2010 Dec; 285(49):38473-85. PubMed ID: 20855886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unraveling Structural Rearrangements of the CFH Gene Cluster in Atypical Hemolytic Uremic Syndrome Patients Using Molecular Combing and Long-Fragment Targeted Sequencing.
    Tschernoster N; Erger F; Walsh PR; McNicholas B; Fistrek M; Habbig S; Schumacher AL; Folz-Donahue K; Kukat C; Toliat MR; Becker C; Thiele H; Kavanagh D; Nürnberg P; Beck BB; Altmüller J
    J Mol Diagn; 2022 Jun; 24(6):619-631. PubMed ID: 35398599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atypical hemolytic uremic syndrome due to factor H autoantibody.
    Uslu-Gökceoğlu A; Doğan CS; Comak E; Koyun M; Akman S
    Turk J Pediatr; 2013; 55(1):86-9. PubMed ID: 23692839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factor H-related proteins determine complement-activating surfaces.
    Józsi M; Tortajada A; Uzonyi B; Goicoechea de Jorge E; Rodríguez de Córdoba S
    Trends Immunol; 2015 Jun; 36(6):374-84. PubMed ID: 25979655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age-related macular degeneration and the role of the complement system.
    McHarg S; Clark SJ; Day AJ; Bishop PN
    Mol Immunol; 2015 Sep; 67(1):43-50. PubMed ID: 25804937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrent structural variation, clustered sites of selection, and disease risk for the complement factor H (
    Cantsilieris S; Nelson BJ; Huddleston J; Baker C; Harshman L; Penewit K; Munson KM; Sorensen M; Welch AE; Dang V; Grassmann F; Richardson AJ; Guymer RH; Graves-Lindsay TA; Wilson RK; Weber BHF; Baird PN; Allikmets R; Eichler EE
    Proc Natl Acad Sci U S A; 2018 May; 115(19):E4433-E4442. PubMed ID: 29686068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atypical hemolytic uremic syndrome-associated variants and autoantibodies impair binding of factor h and factor h-related protein 1 to pentraxin 3.
    Kopp A; Strobel S; Tortajada A; Rodríguez de Córdoba S; Sánchez-Corral P; Prohászka Z; López-Trascasa M; Józsi M
    J Immunol; 2012 Aug; 189(4):1858-67. PubMed ID: 22786770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Case Report: Severe Complement-Mediated Thrombotic Microangiopathy in IgG4-Related Disease Secondary to Anti-Factor H IgG4 Autoantibodies.
    Breville G; Zamberg I; Sadallah S; Stephan C; Ponte B; Seebach JD
    Front Immunol; 2020; 11():604759. PubMed ID: 33643292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains.
    Pickering MC; de Jorge EG; Martinez-Barricarte R; Recalde S; Garcia-Layana A; Rose KL; Moss J; Walport MJ; Cook HT; de Córdoba SR; Botto M
    J Exp Med; 2007 Jun; 204(6):1249-56. PubMed ID: 17517971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoantibodies in haemolytic uraemic syndrome (HUS).
    Skerka C; Józsi M; Zipfel PF; Dragon-Durey MA; Fremeaux-Bacchi V
    Thromb Haemost; 2009 Feb; 101(2):227-32. PubMed ID: 19190803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoimmune forms of thrombotic microangiopathy and membranoproliferative glomerulonephritis: Indications for a disease spectrum and common pathogenic principles.
    Skerka C; Licht C; Mengel M; Uzonyi B; Strobel S; Zipfel PF; Józsi M
    Mol Immunol; 2009 Sep; 46(14):2801-7. PubMed ID: 19640589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Membrano-proliferative glomerulonephritis, atypical hemolytic uremic syndrome, and a new complement factor H mutation: report of a case.
    Gnappi E; Allinovi M; Vaglio A; Bresin E; Sorosina A; Pilato FP; Allegri L; Manenti L
    Pediatr Nephrol; 2012 Oct; 27(10):1995-9. PubMed ID: 22669321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association among Complement Factor H Autoantibodies, Deletions of CFHR, and the Risk of Atypical Hemolytic Uremic Syndrome.
    Jiang H; Fan MN; Yang M; Lu C; Zhang M; Liu XH; Ma L
    Int J Environ Res Public Health; 2016 Dec; 13(12):. PubMed ID: 27929404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H.
    de Córdoba SR; de Jorge EG
    Clin Exp Immunol; 2008 Jan; 151(1):1-13. PubMed ID: 18081690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic influences on plasma CFH and CFHR1 concentrations and their role in susceptibility to age-related macular degeneration.
    Ansari M; McKeigue PM; Skerka C; Hayward C; Rudan I; Vitart V; Polasek O; Armbrecht AM; Yates JR; Vatavuk Z; Bencic G; Kolcic I; Oostra BA; Van Duijn CM; Campbell S; Stanton CM; Huffman J; Shu X; Khan JC; Shahid H; Harding SP; Bishop PN; Deary IJ; Moore AT; Dhillon B; Rudan P; Zipfel PF; Sim RB; Hastie ND; Campbell H; Wright AF
    Hum Mol Genet; 2013 Dec; 22(23):4857-69. PubMed ID: 23873044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-factor H autoantibodies in C3 glomerulopathies and in atypical hemolytic uremic syndrome: one target, two diseases.
    Blanc C; Togarsimalemath SK; Chauvet S; Le Quintrec M; Moulin B; Buchler M; Jokiranta TS; Roumenina LT; Fremeaux-Bacchi V; Dragon-Durey MA
    J Immunol; 2015 Jun; 194(11):5129-38. PubMed ID: 25917093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.